SAT0312 Work Disability in Patients with Systemic Lupus Erythematosus in Moldavian Lupus Study Group. (15th July 2016)
- Record Type:
- Journal Article
- Title:
- SAT0312 Work Disability in Patients with Systemic Lupus Erythematosus in Moldavian Lupus Study Group. (15th July 2016)
- Main Title:
- SAT0312 Work Disability in Patients with Systemic Lupus Erythematosus in Moldavian Lupus Study Group
- Authors:
- Cebanu, M.
Salaru, V.
Sadovici, V.
Mazur-Nicorici, L.
Pasali, M.
Loghin-Oprea, N.
Mazur, M. - Abstract:
- Abstract : Background: As systemic lupus erythematosus (SLE) is a chronic disease, it can lead in time to important functional limitations that impair not only their quality of life but also their ability to work. Prior studies on work disability in patients with SLE have shown that about one third of the patients become disabled within 3–12 years of diagnosis 1, 2 . Objectives: To assess the work disability in patients with systemic lupus erythematosus in Moldavian lupus study group. Methods: Using a cross-sectional design, patients who fulfilled the SLICC (2012) classification criteria for SLE, were recruited from rheumatology departement. Data collection included demographics, disease duration, physician-rated indices of disease activity (SLAM) and damage index (SLICC DI). Work disability was defined by patients self-report. Results: The study included 106 patients (97 females, 9 males) with a mean age (±SD) of 41, 1±12, 6 years, mean disease duration of 90, 0±87, 2 months. The disease activity by SLAM was 11±5, 17 points and mean SLICC/ACR DI 1, 9±2, 4 points. The rate of self-reported work disability among the 106 patients studied was 35, 8% (38 patients). Disability rate in the first year of disease was reported by 39, 5% (15) patients; after 2 to 5 years of disease the estimated rate was of 47, 4% (18 patients); after 6 to 10 years of disease the estimated rate was of 10, 5% (4 patients) and after 10 years of disease the self-reported work disability was 2, 6% (1Abstract : Background: As systemic lupus erythematosus (SLE) is a chronic disease, it can lead in time to important functional limitations that impair not only their quality of life but also their ability to work. Prior studies on work disability in patients with SLE have shown that about one third of the patients become disabled within 3–12 years of diagnosis 1, 2 . Objectives: To assess the work disability in patients with systemic lupus erythematosus in Moldavian lupus study group. Methods: Using a cross-sectional design, patients who fulfilled the SLICC (2012) classification criteria for SLE, were recruited from rheumatology departement. Data collection included demographics, disease duration, physician-rated indices of disease activity (SLAM) and damage index (SLICC DI). Work disability was defined by patients self-report. Results: The study included 106 patients (97 females, 9 males) with a mean age (±SD) of 41, 1±12, 6 years, mean disease duration of 90, 0±87, 2 months. The disease activity by SLAM was 11±5, 17 points and mean SLICC/ACR DI 1, 9±2, 4 points. The rate of self-reported work disability among the 106 patients studied was 35, 8% (38 patients). Disability rate in the first year of disease was reported by 39, 5% (15) patients; after 2 to 5 years of disease the estimated rate was of 47, 4% (18 patients); after 6 to 10 years of disease the estimated rate was of 10, 5% (4 patients) and after 10 years of disease the self-reported work disability was 2, 6% (1 patient). Conclusions: The rate of work disability was 35, 8% with the highest rate in the first five years of disease, affecting younger persons, which make crucial to identify strategies aimed to reduce work disability is in those patients. References: Yelin E, Trupin L, Katz P, Criswell L, Rush S. Prospective study of work dynamics in SLE. Lupus 2005; 14:218. Khanna S, Pal H, Pandey RM, Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology 2004; 43:1536–40. Disclosure of Interest: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 75(2016)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 75(2016)Supplement 2
- Issue Display:
- Volume 75, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 75
- Issue:
- 2
- Issue Sort Value:
- 2016-0075-0002-0000
- Page Start:
- 780
- Page End:
- 780
- Publication Date:
- 2016-07-15
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2016-eular.5516 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18371.xml